HR Execs on the Move


 
C C S is a Haskell, NJ-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Fuji Vegetable Oil Inc

For more than 30 years, Fuji Vegetable Oil has set the standard for quality in plant based oils in North America. With a focused approach to production of palm, palm kernel, coconut and high oleic sunflower oils, Fuji offers a broad portfolio of sustainably sourced products for Food Processors as well as Industrial Manufacturers. Through customization and customer service Fuji is the partner of choice for bulk oils for confectionery, bakery, non-dairy and industrial applications. Fuji produces a broad portfolio of oils in the Port of Savannah, GA specifically for the purpose of processing the highest quality plant-based oils from palm, palm kernel, coconut and sunflower oils.

PETMEDSTORE.COM

PETMEDSTORE.COM is a Lomita, CA-based company in the Business Services sector.

Hawaiian Island Homes - Barry D. Kaplan

Hawaiian Island Homes - Barry D. Kaplan is a Honolulu, HI-based company in the Business Services sector.

Saatchi and Saatchi Los Angeles

Saatchi & Saatchi Los Angeles is a Torrance, CA-based company in the Business Services sector.

Satellos

Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos` lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.